119 related articles for article (PubMed ID: 10871335)
1. Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs.
Gambari R; Feriotto G; Rutigliano C; Bianchi N; Mischiati C
J Pharmacol Exp Ther; 2000 Jul; 294(1):370-7. PubMed ID: 10871335
[TBL] [Abstract][Full Text] [Related]
2. Surface plasmon resonance for real-time detection of molecular interactions between chromomycin and target DNA sequences.
Gambari R; Bianchi N; Rutigliano C; Borsetti E; Tomassetti M; Feriotto G; Zorzato F
Int J Oncol; 1997 Jul; 11(1):145-9. PubMed ID: 21528193
[TBL] [Abstract][Full Text] [Related]
3. Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions.
Passadore M; Feriotto G; Bianchi N; Aguiari G; Mischiati C; Piva R; Gambari R
J Biochem Biophys Methods; 1994 Dec; 29(3-4):307-19. PubMed ID: 7699207
[TBL] [Abstract][Full Text] [Related]
4. Binding of distamycin and chromomycin to human immunodeficiency type 1 virus DNA: a non-radioactive automated footprinting study.
Feriotto G; Mischiati C; Bianchi N; Passadore M; Gambari R
Eur J Pharmacol; 1995 Jul; 290(2):85-93. PubMed ID: 8575537
[TBL] [Abstract][Full Text] [Related]
5. Nuclear magnetic resonance comparison of the binding sites of mithramycin and chromomycin on the self-complementary oligonucleotide d(ACCCGGGT)2. Evidence that the saccharide chains have a role in sequence specificity.
Keniry MA; Banville DL; Simmonds PM; Shafer R
J Mol Biol; 1993 Jun; 231(3):753-67. PubMed ID: 8515449
[TBL] [Abstract][Full Text] [Related]
6. Detection of the deltaF508 (F508del) mutation of the cystic fibrosis gene by surface plasmon resonance and biosensor technology.
Feriotto G; Lucci M; Bianchi N; Mischiati C; Gambari R
Hum Mutat; 1999; 13(5):390-400. PubMed ID: 10338094
[TBL] [Abstract][Full Text] [Related]
7. Intra- and intermolecular triplex DNA formation in the murine c-myb proto-oncogene promoter are inhibited by mithramycin.
Vigneswaran N; Thayaparan J; Knops J; Trent J; Potaman V; Miller DM; Zacharias W
Biol Chem; 2001 Feb; 382(2):329-42. PubMed ID: 11308031
[TBL] [Abstract][Full Text] [Related]
8. DNA binding characteristics of mithramycin and chromomycin analogues obtained by combinatorial biosynthesis.
Barceló F; Ortiz-Lombardía M; Martorell M; Oliver M; Méndez C; Salas JA; Portugal J
Biochemistry; 2010 Dec; 49(49):10543-52. PubMed ID: 21067184
[TBL] [Abstract][Full Text] [Related]
9. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
[TBL] [Abstract][Full Text] [Related]
10. Distamycin A affects the stability of NF-kappaB p50-DNA complexes in a sequence-dependent manner.
Speight RE; Hart DJ; Blackburn JM
J Mol Recognit; 2002; 15(1):19-26. PubMed ID: 11870918
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of Bt-176 maize genomic sequences by surface plasmon resonance-based biospecific interaction analysis of multiplex polymerase chain reaction (PCR).
Feriotto G; Gardenghi S; Bianchi N; Gambari R
J Agric Food Chem; 2003 Jul; 51(16):4640-6. PubMed ID: 14705890
[TBL] [Abstract][Full Text] [Related]
12. Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription.
Bianchi N; Rutigliano C; Passadore M; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):919-27. PubMed ID: 9307046
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target.
Remsing LL; Bahadori HR; Carbone GM; McGuffie EM; Catapano CV; Rohr J
Biochemistry; 2003 Jul; 42(27):8313-24. PubMed ID: 12846580
[TBL] [Abstract][Full Text] [Related]
14. Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: effects of the DNA-binding drug chromomycin.
Rutigliano C; Bianchi N; Tomassetti M; Pippo L; Mischiati C; Feriotto G; Gambari R
Int J Oncol; 1998 Feb; 12(2):337-43. PubMed ID: 9458359
[TBL] [Abstract][Full Text] [Related]
15. Determination of binding constant of DNA-binding drug to target DNA by surface plasmon resonance biosensor technology.
Lin LP; Huang LS; Lin CW; Lee CK; Chen JL; Hsu SM; Lin S
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):61-72. PubMed ID: 15777205
[TBL] [Abstract][Full Text] [Related]
16. Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons.
Chatterjee S; Zaman K; Ryu H; Conforto A; Ratan RR
Ann Neurol; 2001 Mar; 49(3):345-54. PubMed ID: 11261509
[TBL] [Abstract][Full Text] [Related]
17. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction.
Bell A; Kittler L; Löber G; Zimmer C
J Mol Recognit; 1997; 10(6):245-55. PubMed ID: 9770648
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
19. Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNAase I footprinting study.
Feriotto G; Mischiati C; Gambari R
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):451-8. PubMed ID: 8172606
[TBL] [Abstract][Full Text] [Related]
20. Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Disruption of nuclear factor.DNA complexes and inhibition of in vitro transcription.
Bianchi N; Passadore M; Rutigliano C; Feriotto G; Mischiati C; Gambari R
Biochem Pharmacol; 1996 Nov; 52(10):1489-98. PubMed ID: 8937462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
